Evidence map›Paper›PMID 32420499›Full record

ArticleHeliyon2020

M Carmen Guillén, M Magdalena Alcover, Natalia Borruel, Elena Sulleiro, Fernando Salvador, Diana Berenguer, Claudia Herrera-de Guise, Verónica Rodríguez, Zaira Moure, Adrián Sánchez-Montalvà and 3 more

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Case Report: Cutaneous Leishmaniasis Misdiagnosed as Pyoderma Gangrenosum.The American journal of tropical medicine and hygiene · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

M Carmen GuillénLaboratory of Parasitology, Department of Biology, Health and Environment, Faculty of Pharmacy and Food Science, University of Barcelona, Avda Joan XXIII, 27-31, 08028, Barcelona, Spain.
M Magdalena AlcoverLaboratory of Parasitology, Department of Biology, Health and Environment, Faculty of Pharmacy and Food Science, University of Barcelona, Avda Joan XXIII, 27-31, 08028, Barcelona, Spain.
Natalia BorruelCrohn's and Colitis Attention Unit, Vall d'Hebron University Hospital, Ps Vall d'Hebron, 119-129, 08035, Barcelona, Spain.
Elena SulleiroDepartment of Microbiology, Vall d'Hebron University Hospital, PROSICS, Ps Vall d'Hebron, 119-129, 08035, Barcelona, Spain.
Fernando SalvadorDepartment of Infectious Diseases, Vall d'Hebron University Hospital, PROSICS Barcelona, Ps Vall d'Hebron, 119-129, 08035, Barcelona, Spain.
Diana BerenguerLaboratory of Parasitology, Department of Biology, Health and Environment, Faculty of Pharmacy and Food Science, University of Barcelona, Avda Joan XXIII, 27-31, 08028, Barcelona, Spain.
Claudia Herrera-de GuiseCrohn's and Colitis Attention Unit, Vall d'Hebron University Hospital, Ps Vall d'Hebron, 119-129, 08035, Barcelona, Spain.
Verónica RodríguezCrohn's and Colitis Attention Unit, Vall d'Hebron University Hospital, Ps Vall d'Hebron, 119-129, 08035, Barcelona, Spain.
Zaira MoureDepartment of Microbiology, Vall d'Hebron University Hospital, PROSICS, Ps Vall d'Hebron, 119-129, 08035, Barcelona, Spain.
Adrián Sánchez-MontalvàDepartment of Infectious Diseases, Vall d'Hebron University Hospital, PROSICS Barcelona, Ps Vall d'Hebron, 119-129, 08035, Barcelona, Spain.
Israel MolinaDepartment of Infectious Diseases, Vall d'Hebron University Hospital, PROSICS Barcelona, Ps Vall d'Hebron, 119-129, 08035, Barcelona, Spain.
Roser FisaLaboratory of Parasitology, Department of Biology, Health and Environment, Faculty of Pharmacy and Food Science, University of Barcelona, Avda Joan XXIII, 27-31, 08028, Barcelona, Spain.
Cristina RieraLaboratory of Parasitology, Department of Biology, Health and Environment, Faculty of Pharmacy and Food Science, University of Barcelona, Avda Joan XXIII, 27-31, 08028, Barcelona, Spain.
Vall d'Hebron Hospital Universitari · ESUniversitat de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn recent years anti-TNF therapy has been associated with leishmaniasis in immunocompromised patients from endemic areas. Nevertheless, data on asymptomatic

methods192 IBD patients (143 Crohn's disease; 49 ulcerative colitis) from Catalonia (Spain), an area endemic for

resultsSerology was positive in 3.1% and

conclusionThe prevalence of

Indexed as

Anti-TNFBiological sciencesHealth sciencesIBDImmunologyInfectious diseaseLeishmaniaParasitology

Identifiers

PMID32420499
PMCPMC7218013
OpenAlexW3022130984

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.